![Robert Z. Orlowski](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenienza dei contatti di primo grado di Robert Z. Orlowski
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Asylia Therapeutics, Inc.
![]() Asylia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Asylia Therapeutics, Inc. is a private biotechnology company founded in 2019 by Richard Jones, Robert Z. Orlowski, and Ronald A. DePinho. The company is based in Houston, TX. Asylia Therapeutics is focused on developing novel immune modulating therapies for cancer and autoimmune diseases. The company's drug pipeline is capable of modulating antigen presentation to the immune system, which has produced anti-tumor responses across multiple cancer models. The company is supported by a $3 million grant from the Cancer Prevention & Research Institute of Texas. The CEO is Karthik Radhakrishnan.
9
| Holding Company | Pharmaceuticals: Major | 9 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Robert Z. Orlowski tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Biogen MA, Inc.
![]() Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Biotechnology | Corporate Officer/Principal | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Eagle Asset Management, Inc.
![]() Eagle Asset Management, Inc. Investment ManagersFinance Eagle Asset Management, Inc. (Eagle) is a SEC-registered investment advisor headquartered in St. Petersburg, Florida. The firm was founded in 1976 by Tom James and is a wholly owned subsidiary of Carillon Towers Advisers, Inc., which is wholly owned by Raymond James Financial, Inc. (NYSE: RJF). Eagle provides portfolio management services to institutions and high net-worth clients (individual investors, trusts and smaller employee benefit plans) and serves as the investment subadvisor to the Carillon Funds. | Investment Managers | Analyst-Equity | |
Voya Investment Management Co. LLC
![]() Voya Investment Management Co. LLC Investment ManagersFinance Voya Investment Management Co. LLC (Voya IM) is a SEC-registered investment advisor and mutual fund manager headquartered in New York City. Formerly known as ING Investment Management Co. LLC, the firm was founded in 1972 under the name of Aetna Capital Management, Inc. They are a wholly-owned subsidiary of Voya Investment Management LLC, ultimately held by Voya Financial, Inc. (NYSE: VOYA). Voya IM provides investment management services to a wide range of clients and investment vehicles. | Investment Managers | Analyst-Equity | |
OVID THERAPEUTICS INC. | Pharmaceuticals: Major | President | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree | |
MIRATI THERAPEUTICS | Biotechnology | Chief Tech/Sci/R&D Officer | |
Case Western Reserve University
![]() Case Western Reserve University Other Consumer ServicesConsumer Services Case Western Reserve University provides educational services. It offers a variety of undergraduate degree courses and graduate and professional options such as arts and sciences, dentistry, engineering, law, management, medicine, nursing, social work, and more. The firm also offers dual-degree programs. The company was founded in 1826 and is headquartered in Cleveland, OH. | College/University | Doctorate Degree | |
The University of Texas at Austin | College/University | Undergraduate Degree | |
University of California, Berkeley | College/University | Undergraduate Degree | |
University of Michigan | College/University | Masters Business Admin | |
Indian Institute of Technology New Delhi | College/University | Undergraduate Degree | |
AVEO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Operating Officer Chief Tech/Sci/R&D Officer Founder | |
The State University of New York | College/University | Graduate Degree | |
The University of Texas M.D. Anderson Cancer Center
![]() The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Other Consumer Services | Chief Executive Officer | |
The New York City Investment Fund Manager, Inc.
![]() The New York City Investment Fund Manager, Inc. Investment ManagersFinance The New York City Investment Fund Manager Inc. (The New York City Investment Fund Manager) is a venture capital firm founded by Henry Kravis in 1996. The firm is headquartered in New York, United States. | Investment Managers | Consultant / Advisor | |
Weizmann Institute of Science | College/University | Director/Board Member | |
London Business School | College/University | Masters Business Admin | |
Greater Houston Partnership Inc
![]() Greater Houston Partnership Inc Investment Trusts/Mutual FundsMiscellaneous Greater Houston Partnership operates as a place for community-minded business leaders who want to be involved in Houston''s positive growth and influence the direction. The company was founded in 1840 and is headquartered in Houston, TX. | Investment Trusts/Mutual Funds | Director/Board Member | |
American Academy of Arts & Sciences
![]() American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The American Academy of Arts & Sciences is an organization that honors excellence and brings together leaders. The non-profit company is based in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
BioHouston, Inc.
![]() BioHouston, Inc. Miscellaneous Commercial ServicesCommercial Services BioHouston, Inc. engages in life science and biotechnology commercialization. The firm's mission is to create an environment that will stimulate technology transfer and research commercialization, thereby generating economic wealth for the Houston region and making it a global competitor in life science commercialization. The company is headquartered in Houston, TX. | Miscellaneous Commercial Services | Director/Board Member | |
Technology & Entrepreneurship Center of Houston
![]() Technology & Entrepreneurship Center of Houston Investment ManagersFinance Technology & Entrepreneurship Center of Houston operates as a non-profit organization created to accelerate the growth of Houston’s innovation ecosystem. It aligns ecosystem support around strategic initiatives that are connecting, attracting, and promoting startups, investors, corporations, government, and universities. The company was founded in October 2017 and is headquartered in Houston, TX. | Investment Managers | Director/Board Member | |
The Board of Regents of The University of Texas System
![]() The Board of Regents of The University of Texas System General GovernmentGovernment Part of The University of Texas at Austin, The Board of Regents of The University of Texas System oversees college activities. The company is based in Austin, TX. | General Government | Corporate Officer/Principal | |
CytomX Therapeutics Holdings LLC
![]() CytomX Therapeutics Holdings LLC Pharmaceuticals: MajorHealth Technology CytomX Therapeutics Holdings LLC engaged in the development of new generation targeted antibody therapeutics. The company was founded by Frederick W. Gluck on January 31, 2008 and is headquartered in Santa Barbara, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Albert Einstein College of Medicine, Inc. | College/University | Doctorate Degree | |
Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal | |
AstraZeneca LP
![]() AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Columbia Business School | College/University | Masters Business Admin | |
IMMUNEERING CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
Vanderbilt University School of Medicine | College/University | Graduate Degree | |
Tufts University School of Medicine | College/University | Doctorate Degree | |
CYTOMX THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
XILIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
BoxCar Partners LLC | Founder | ||
BLACK DIAMOND THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Tvardi Therapeutics, Inc.
![]() Tvardi Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tvardi Therapeutics, Inc. develops and commercializes medicines for the treatment of diverse cancers, chronic inflammatory and fibrotic diseases. The company was founded by David J. Tweardy and Ronald A. DePinho in 2017 and is headquartered in Houston, TX. | Miscellaneous Commercial Services | Director/Board Member Consultant / Advisor Founder | |
Sporos Bioventures, Inc.
![]() Sporos Bioventures, Inc. Medical/Nursing ServicesHealth Services Sporos Bioventures, Inc. is a private biopharmaceutical company based in Houston, TX. Sporos Bioventures, Inc. aims to transform the drug development process by identifying novel disease mechanisms and strategically deploying talent, capital, and access to operational resources to catalyze the development of breakthrough medicines. Sporos' current pipeline is diversified across three business units and includes multiple clinical-stage candidates that are being investigated for the treatment of multiple indications in cancer and immune disease. The company provides centralized expertise, resources, and core infrastructure so that the portfolio companies can focus primarily on their research development programs. The company was founded by Peter Feinberg, Ronald A. DePinho, Jeno Gyuris, Joseph Kekst, Harold Levy, Alex M. Cranberg, Louis Feinberg, Michael S. Wyzga, Dana Levy, and the CEO is Stephen Rubino. | Medical/Nursing Services | Founder Chief Executive Officer Founder Founder Director/Board Member Chief Executive Officer Founder | |
Nirogy Therapeutics, Inc.
![]() Nirogy Therapeutics, Inc. BiotechnologyHealth Technology Nirogy Therapeutics, Inc. is an American biotechnology company that operates in the healthcare industry. The company is based in N/A. The company was founded in 2014 by Vincent Sandanayaka, Jaime Escobedo. Simon C. Pedder has been the CEO of the company since 2022. | Biotechnology | Director/Board Member Director/Board Member | |
Flare Therapeutics, Inc.
![]() Flare Therapeutics, Inc. BiotechnologyHealth Technology Flare Therapeutics is a biotechnology company that focuses on drugging transcription factors to develop small molecule medicines. The company is based in Cambridge, MA. The company's integrated discovery engine converges genetic, biochemical, and chemical insights to reveal druggable pockets and identify small molecule ligands capable of modulating transcription factors of high therapeutic potential. Flare's proteomic and mass spectrometry platform is powered by a proprietary library of electrophilic compounds unique to the company. The team has rapidly established an emerging pipeline of programs, highlighted by FX-909, a first-in-class investigational orally bioavailable small molecule inhibitor of PPARG, a master regulator of the luminal lineage in advanced urothelial cancer that has entered the clinic. Flare Therapeutics was launched in 2021 and is backed by founding investor Third Rock Ventures, as well as Boxer Capital, Nextech Invest, Casdin Capital, Invus Financial Advisors, and Eventide Asset Management. The company was founded by Mitchell Lazar, Fraydoon Rastinejad, Robert J. Sims, and Steven L. McKnight. Amit Rakhit has been the CEO of the company since 2022. | Biotechnology | Chief Executive Officer | |
PYXIS ONCOLOGY, INC. | Pharmaceuticals: Major | Director/Board Member | |
EFFECTOR THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
The Greater Boston Food Bank
![]() The Greater Boston Food Bank Miscellaneous Commercial ServicesCommercial Services The Greater Boston Food Bank is the largest hunger-relief organization in the country, providing nearly 90 million meals per year to people in 190 towns across the region. The Greater Boston Food Bank is based in Boston, MA. The organization is committed to ending hunger and believes that access to healthy food is a human right. The non-profit company works towards this goal through policy, partnerships, and providing free, nutritious, and culturally responsive food. Catherine D'Amato has been the CEO of the company since 1995. | Miscellaneous Commercial Services | Director/Board Member |
Statistiche
Distribuzione geografica
Stati Uniti | 43 |
India | 2 |
Israele | 2 |
Regno Unito | 2 |
Settori
Health Technology | 19 |
Consumer Services | 16 |
Finance | 5 |
Commercial Services | 5 |
Miscellaneous | 2 |
Posizioni
Director/Board Member | 38 |
Corporate Officer/Principal | 27 |
Founder | 16 |
Chief Tech/Sci/R&D Officer | 9 |
President | 8 |
Contatti più connessi
Insiders | |
---|---|
Ronald DePinho | 20 |
Elan Ezickson | 17 |
Rachel Humphrey | 17 |
Alex M. Cranberg | 16 |
Amit Rakhit | 13 |
Jeno Gyuris | 11 |
Karthik Radhakrishnan | 8 |
Joseph Kekst | 7 |
Richard Jones | 1 |
- Borsa valori
- Insiders
- Robert Z. Orlowski
- Connessioni Società